The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)
Launched by ZHIJUN BAO · Nov 11, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 18 years old, with no gender limit;
- • Histologically confirmed or clinically diagnosed as pancreatic cancer by MDT (multidisciplinary team), without histopathological evidence;
- • Patients may receive LPD or OPD according to the MDT evaluation;
- • Patients understand and are willing to comply with the trial;
- • Signed written informed consent before patient enrollment;
- • Patients who meet the clinical guidelines for intent to treat.
- • Those who met each of the above criteria were included in the study.
- Exclusion Criteria:
- • Patients with distant metastasis found before or during surgery, including peritoneal, liver, distant lymph node metastasis, and other organ involvement;
- • Patients who need pancreatic neck or pancreatic tail, total pancreatic resection or other palliative surgery;
- • Preoperative anesthesia ASA score of 4 points;
- • A history of other malignant tumors;
- • Pregnant or lactating women;
- • Patients with severe mental disorders;
- • MDT evaluates patients with vascular invasion and requiring vascular resection based on abdominal imaging data;
- • Patients who have participated in other clinical trials within 3 months. Those who meet any of the above criteria were not included in the study.
About Zhijun Bao
Zhijun Bao is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, the organization specializes in designing and executing clinical trials across various therapeutic areas. Leveraging extensive expertise in regulatory compliance and best practices, Zhijun Bao collaborates with healthcare professionals and institutions to ensure the efficient and ethical conduct of studies. Their mission is to contribute to the development of groundbreaking therapies that address unmet medical needs and improve the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported